AAD  Vol.5 No.3 , September 2016
Psychophysiological Effects of a Combination of Sideritis and Bacopa Extract (memoLoges®) in 32 Subjects Suffering from Mild Cognitive Impairment. A Double-Blind, Randomized, Placebo-Controlled, 2-Armed Study with Parallel Design
Abstract: Mild cognitive impairment (MCI) can be regarded as a non-demented transitional stage during the development of Alzheimer’s disease. Early recognition of this stage might increase the chance of prevention by early treatment. Within a pilot study, two plant-derived preparations and mixtures thereof were tested successfully in subjects suffering from MCI. A combination of Sideritis scardica and Bacopa monnieri extract (memoLoges®) was chosen now for a repetitive dosing during 4 weeks. Thirty-two subjects aged 50 to 80 years and suffering from MCI (having a DemTect questionnaire score between 8 and 13) were recruited for intake of 2 capsules of the preparation per day. Quantitative EEG recording during relaxation and concomitant performance of three 5 minutes lasting psychometric tests (d2-concentration test, arithmetic calculation test and memory test) was achieved at the first day and one day after the last repetitive intake. Seventeen channels of EEG and one channel EOG (for artefact rejection) were recorded. After frequency analysis (FFT) current source density was calculated as reported earlier. One, two and three hours after intake of the herbal extract or placebo the whole procedure was repeated. Brain imaging was achieved by conversion of numerical values of spectral EEG power into spectral colors and additive color mixture according to RGB as used in TV settings. Intake of memoLoges® induced a trend of improvement of performance in psychometric testing (all three tests). During relaxation quantitative assessment of EEG data revealed attenuation of delta and theta spectral power in frontal brain as likewise reported in the presence of the Alzheimer drug rivastigmine, bringing the spectrum back to “normality”. During mental work memoLoges® induced statistically significant increases of beta power. Since MCI subjects produce less beta power in comparison to healthy subjects, this increase must likewise be seen as a positive effect pointing to a healthier spectrum.
Cite this paper: Dimpfel, W. , Biller, A. , Suliman, S. and Dipah, G. (2016) Psychophysiological Effects of a Combination of Sideritis and Bacopa Extract (memoLoges®) in 32 Subjects Suffering from Mild Cognitive Impairment. A Double-Blind, Randomized, Placebo-Controlled, 2-Armed Study with Parallel Design. Advances in Alzheimer's Disease, 5, 103-125. doi: 10.4236/aad.2016.53008.

[1]   Forlenza, O.V., Diniz, B.S., Stella, F., Texeira, A. and Gattaz, W.F., (2013) Mild Cognitive Impairment (Part 1): Clinical Characteristics and Predictors of Dementia. Revista Brasileira de Psiquiatria, 35, 178-185.

[2]   Dimpfel, W. (2014) Neurophysiologial Biomarker of Mild Cognitive Impairment. Advances in Alzheimer’s Disease, 3, 64-77.

[3]   Corradini, P.L. and Persinger, M.A. (2015) Replace Psychometric Inferences with Direct Brain Measurements: LORETA Reflects Traditional Cerebral Loci for Neuropsychological Tests. Neuroscience & Medicine, 6, 107-115.

[4]   Caravaglios, G., Muscoso, E.G., Di Maria, G. and Costanzo, E. (2015) Patients with Mild Cognitive Impairment Have Abnormal Upper-Alpha Event-Related Desynchronization/Synchronization (ERD/ERS) during a Task of Temporal Attention. Journal of Neural Transmission, 122, 441-453.

[5]   Cedarbaum, J.M., Crans, G. and Grundman, M. (2010) Seeing with New Eyes: Finding a Path to Early Intervention Trials in Alzheimer’s Disease. The Journal of Nutrition Health and Aging, 14, 306-309.

[6]   Almkvist, O., Basun, H., Bäckmann, L., Herlitz, A., Lanfelt, L., Small, B., Viitanen, M., Wahlund, M.O. and Winblad, B. (1998) Mild Cognitive Impairment—An Early Stage of Alzheimer’s Disease? Journal of Neural Transmission/Supplementum, 54, 21-29.

[7]   Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A.P., Brand, M. and Bullock, R. (2004) DemTect: A New, Sensitive Cognitive Screening Test to Support the Diagnosis of Mild Cognitive Impairment and Early Dementia. International Journal of Geriatric Psychiatry, 19, 136-143.

[8]   Kessler, J., Calabrese, P., Kalbe, E. and Berger. F. (2000) DemTect. Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psycho, 26, 343-347.

[9]   Dimpfel, W., Koch, K. and Weiss, G. (2011) Early Effect of NEURAPAS® Balance on Current Source Density (CSD) of Human EEG. BMC Psychiatry, 11, 123-138.

[10]   Harmony, T., Fernandez-Bouzas, A., Marosi, E., Fernandez, T., Bernal, J., Rodriguez, M., Reyes, A., Silva, J., Alonso, M. and Casian, G. (1993) Correlation between Computed Tomography and Voltage and Current Source Density Spectral. Parameters in Patients with Brain Lesions. Electroencephalography and Clinical Neurophysiology, 87, 196-205.

[11]   Dimpfel, W., Hofmann, H.C., Prohaska. A., Schober, F. and Schellenberg, R. (1996) Source Density Analysis of Functional Topographical EEG: Monitoring of Cognitive Drug Action. European Journal of Medical Research, 1, 283-290.

[12]   Dimpfel, W. (2015) Drug Discovery and Translational Medicine Based on Neurophysiological Techniques. A holistic Approach to Saving Animals. Books on Demand, Norderstedt.

[13]   Schober, F., Schellenberg, R. and Dimpfel, W. (1995) Reflection of Mental Exercise in the Dynamic Quantitative Topographical EEG. Neurobiology, 31, 98-112.

[14]   Gianotty, L.R., Künig, G., Faber, P.L., Lehmann, D., Pascual-Marqui, R.D., Kochi, K. and Schreiter-Gasser, U. (2008) Rivastigmine Effects on EEG Spectra and Three-Dimensional LORETA Functional Imaging in Alzheimer’s Disease. Psychopharmacology, 198, 323-332.

[15]   Dimpfel, W., ChiegouaDipah, G.N. and Gericke, N. (2016) EnkephaloVision: Anatomical Functionality Indicated by Ultrashort Transient Regional EEG Spectral Power Changes during Cognitive and Emotional Challenges. World Journal of Neuroscience, 6, 90-110.

[16]   Kroll, N.E.A., Markowwitsch, H.J., Knight, R.T. and Cramon, D.Y. (1997) Retrieval of Old Memories: The Temporofrontal Hypothesis. Brain, 120, 1377-1399.

[17]   Dimpfel, W., Schombert, L. and Biller, A. (2016) Psychophysiological Effects of Sideritis and Bacopa Extract and Three Combinations Thereof—A Quantitative EEG Study in Subjects Suffering from Mild Cognitive Impairment (MCI). Advances in Alzheimer’s Disease, 5, 1-22.